New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Precision magnetics could be game-changer for therapy-resistant brain cancers

Precision magnetics could be game-changer for therapy-resistant brain cancers

by The Hospital for Sick ChildrenArtistic rendering illustrating how the mechanical nanosurgery, a new approach developed by SickKids and University of Toronto researchers, targets cancer cells from i
World medicine December 10,2023
Precision magnetics could be game-changer for therapy-resistant brain cancers

Precision magnetics could be game-changer for therapy-resistant brain cancers

by The Hospital for Sick ChildrenArtistic rendering illustrating how the mechanical nanosurgery, a new approach developed by SickKids and University of Toronto researchers, targets cancer cells from i
World medicine December 10,2023
Minimizing fallout from explosive cell death could slow inflammation, cancer spread

Minimizing fallout from explosive cell death could slow inflammation, cancer spread

by Tom Dinki,University at BuffaloA study from the lab of University at Buffalo chemistry professor G. Ekin Atilla-Gokcumen has revealed the mechanism behind an explosive form of cell death know
World medicine December 10,2023
Minimizing fallout from explosive cell death could slow inflammation, cancer spread

Minimizing fallout from explosive cell death could slow inflammation, cancer spread

by Tom Dinki,University at BuffaloA study from the lab of University at Buffalo chemistry professor G. Ekin Atilla-Gokcumen has revealed the mechanism behind an explosive form of cell death know
World medicine December 10,2023
Head and neck cancer diagnostic delays linked to antibiotics despite clinical practice guidelines

Head and neck cancer diagnostic delays linked to antibiotics despite clinical practice guidelines

by Bridjes O'Neil,Saint Louis UniversityCredit: Unsplash/CC0 Public DomainResearchers at Saint Louis University School of Medicine say diagnostic delays frequently occur in patients with und
World medicine December 10,2023
Head and neck cancer diagnostic delays linked to antibiotics despite clinical practice guidelines

Head and neck cancer diagnostic delays linked to antibiotics despite clinical practice guidelines

by Bridjes O'Neil,Saint Louis UniversityCredit: Unsplash/CC0 Public DomainResearchers at Saint Louis University School of Medicine say diagnostic delays frequently occur in patients with und
World medicine December 10,2023
Money troubles can delay cancer diagnoses, putting survival in jeopardy

Money troubles can delay cancer diagnoses, putting survival in jeopardy

by Alan MozesMoney woes have long been linked to worse health care. Now, a new study finds financially strapped patients often put off cancer screenings—only to learn they have the disease when it&#39
World medicine December 10,2023
Money troubles can delay cancer diagnoses, putting survival in jeopardy

Money troubles can delay cancer diagnoses, putting survival in jeopardy

by Alan MozesMoney woes have long been linked to worse health care. Now, a new study finds financially strapped patients often put off cancer screenings—only to learn they have the disease when it&#39
World medicine December 10,2023
Decoding the mechanism behind MCL-1 inhibitors: A pathway to understanding MCL-1 protein stability

Decoding the mechanism behind MCL-1 inhibitors: A pathway to understanding MCL-1 protein stability

by Impact Journals LLCFigure 1: Mechanisms of MCL-1 inhibitor-induced MCL-1 protein upregulation, stability, and induction of apoptosis. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.2
World medicine December 10,2023
Decoding the mechanism behind MCL-1 inhibitors: A pathway to understanding MCL-1 protein stability

Decoding the mechanism behind MCL-1 inhibitors: A pathway to understanding MCL-1 protein stability

by Impact Journals LLCFigure 1: Mechanisms of MCL-1 inhibitor-induced MCL-1 protein upregulation, stability, and induction of apoptosis. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.2
World medicine December 10,2023
Addressing cancer concerns in the LGBTQ+ community

Addressing cancer concerns in the LGBTQ+ community

by Deb BalzerCredit: Pixabay/CC0 Public DomainDuring June, many cities and towns around the U.S. and the world celebrate and raise awareness of the LGBTQ+ community's accomplishments and the ongoi
World medicine December 10,2023
Addressing cancer concerns in the LGBTQ+ community

Addressing cancer concerns in the LGBTQ+ community

by Deb BalzerCredit: Pixabay/CC0 Public DomainDuring June, many cities and towns around the U.S. and the world celebrate and raise awareness of the LGBTQ+ community's accomplishments and the ongoi
World medicine December 10,2023
Deconstructing the role of MALAT1 in MAPK-signaling in melanoma

Deconstructing the role of MALAT1 in MAPK-signaling in melanoma

by Impact Journals LLCMALAT1-ASO specifically targets MALAT1-lncRNAs. (A) Schematic illustration of the MALAT1-ASO bypassing the cell-membrane and entering the nucleus of melanoma cells to inhibit MAL
World medicine December 10,2023
Deconstructing the role of MALAT1 in MAPK-signaling in melanoma

Deconstructing the role of MALAT1 in MAPK-signaling in melanoma

by Impact Journals LLCMALAT1-ASO specifically targets MALAT1-lncRNAs. (A) Schematic illustration of the MALAT1-ASO bypassing the cell-membrane and entering the nucleus of melanoma cells to inhibit MAL
World medicine December 10,2023
Deciphering progesterone's mechanisms of action in breast cancer

Deciphering progesterone's mechanisms of action in breast cancer

by Impact Journals LLCAn integrated representation of the multifaceted effects of progesterone in breast cancer. A schematic representation to describe the molecular mechanisms by which progesterone a
World medicine December 10,2023
Deciphering progesterone's mechanisms of action in breast cancer

Deciphering progesterone's mechanisms of action in breast cancer

by Impact Journals LLCAn integrated representation of the multifaceted effects of progesterone in breast cancer. A schematic representation to describe the molecular mechanisms by which progesterone a
World medicine December 10,2023
Gains in colorectal cancer outcomes slowing, reversing

Gains in colorectal cancer outcomes slowing, reversing

by Lori SolomonDecreases in colorectal cancer (CRC) diagnoses and deaths among adults in their 50s and 60s have slowed compared with previous decades, according to a study recently published inC
World medicine December 10,2023
Gains in colorectal cancer outcomes slowing, reversing

Gains in colorectal cancer outcomes slowing, reversing

by Lori SolomonDecreases in colorectal cancer (CRC) diagnoses and deaths among adults in their 50s and 60s have slowed compared with previous decades, according to a study recently published inC
World medicine December 10,2023
Genetic switch turns tumor suppressor into oncogene in colorectal cancer

Genetic switch turns tumor suppressor into oncogene in colorectal cancer

by Liana F. Wait,University of PennsylvaniaInhibiting the enzyme NOTUM slowed cancer growth and prevented metastasis in an animal model of colorectal cancer. Credit: Yuhua TianColorectal cancer
World medicine December 10,2023
Genetic switch turns tumor suppressor into oncogene in colorectal cancer

Genetic switch turns tumor suppressor into oncogene in colorectal cancer

by Liana F. Wait,University of PennsylvaniaInhibiting the enzyme NOTUM slowed cancer growth and prevented metastasis in an animal model of colorectal cancer. Credit: Yuhua TianColorectal cancer
World medicine December 10,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com